Stockscreener 앱 받기
7.79
1.39%
-0.11
시간 외 거래:
7.79
Cumberland Pharmaceuticals Inc 주식(CPIX)의 최신 뉴스
Enterprise value to revenue forward of Cumberland Pharmaceuticals Inc. – NASDAQ:CPIX - TradingView
Price to book forward of Cumberland Pharmaceuticals Inc. – NASDAQ:CPIX - TradingView
Cumberland Pharmaceuticals: Pivot Into Drug Development Creates Risk, Opportunity (CPIX) - Seeking Alpha
Cumberland Pharmaceuticals (NASDAQ:CPIX) Share Price Passes Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Cumberland Pharmaceuticals (CPIX) Slips 1.04% as Shares Test Key Support Near $7.22Volume Profile - dars.gov.et
Cumberland Pharmaceuticals (CPIX) Stock Cools As Cash Rich Biotech Pivot Begins - Sahm
Cumberland Pharmaceuticals Inc (CPIX) (Q2 2026) Earnings Call Highlights: Strategic ... - Yahoo Finance
Earnings call transcript: Cumberland Pharmaceuticals swings on Q2 2026 reset - Investing.com
Cumberland Pharmaceuticals Q2 Earnings Call Highlights - MarketBeat
Cumberland Pharmaceuticals Q2 loss widens after Apotex transaction - TradingView
Cumberland Pharmaceuticals (NASDAQ:CPIX) Issues Quarterly Earnings Results - MarketBeat
Cumberland Pharmaceuticals posts $4.1 million Q2 loss after Apotex deal - Quiver Quantitative
Cumberland Pays $1.50 Dividend After Apotex Brand Sale - Stock Titan
Cumberland Pharmaceuticals Inc (CPIX) (Q2 2026) Earnings Call Highlights: Strategic ... By GuruFocus - Investing.com Canada
ETFs Investing in Cumberland Pharmaceuticals Inc. Stocks - TradingView
Possible Generic Drug Tariffs and 2 Microcaps - TradingView
Cumberland Pharmaceuticals Q2 Results: Company update and earnings call set for Aug 4 - scanx.trade
Cumberland Pharmaceuticals Inc (CPIX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CPIX|Cumberland Pharmaceuticals Inc|Price:7.030|Chg%:+0.420 - TradingKey
Cumberland Pharmaceuticals Inc. Revenue Breakdown – NASDAQ:CPIX - TradingView
TradingKey - TradingKey
Cumberland Pharmaceuticals Inc (CPIX) Institutional Confidence - TradingKey
Cumberland Pharmaceuticals Inc (CPIX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Cumberland Pharmaceuticals Inc (CPIX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cumberland Pharmaceuticals Inc - TradingKey
CPIX|Cumberland Pharmaceuticals Inc|Price:6.610|Chg%:-0.375 - TradingKey
Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Price Passes Above 200 Day Moving AverageHere's What Happened - MarketBeat
Cumberland Pharmaceuticals | 8-K: Current report - Moomoo
Cumberland Pharmaceuticals declares $1.50 dividend - MSN
Cumberland Pharmaceuticals Inc. (CPIX) Gains Momentum, Approaches Key Resistance LevelNHNL Divergence - po-news-eg.net
Cumberland Pharma Board of Directors Has Authorized and Declared a Special Cash Div of $1.50 a Shr >CPIX - Moomoo
ELTP vs. CPIX: Which Pharma Stock Is the Better Buy Right Now? - The Globe and Mail
BRIEF-Cumberland Pharmaceuticals Announces Special Dividend Of $1.50 Per Share - Dailyhunt
Cumberland Pharmaceuticals 8-K Filing July 2026: Key Company Details, Stock Info, and Address on NASDAQ CPIX - Minichart
Cumberland Pharmaceuticals Announces Special Dividend, Share Buyback - TipRanks
Cumberland Pharmaceuticals declares $1.50 special dividend, $5M buyback after $100M Apotex deal - TradingView
Cumberland Pharmaceuticals (Nasdaq: CPIX) returns cash after $100M Apotex deal - Stock Titan
Cumberland Pharmaceuticals Inc. (CPIX) Stock: Unveils Special Dividend While Advancing Ifetroban Rare Disease Pipeline - parameter.io
Cumberland Pharmaceuticals Announces Special Dividend, Payable on July 31, 2026 - marketscreener.com
Press Release: CUMBERLAND PHARMACEUTICALS ANNOUNCES SPECIAL DIVIDEND OF $1.50 PER SHARE - Moomoo
/C O R R E C T I O N -- Cumberland Pharmaceuticals Inc./ - Yahoo Finance
Cumberland Pharmaceuticals Announces Special Dividend Of $1.50 Per Share - TradingView
CUMBERLAND PHARMACEUTICALS ANNOUNCES SPECIAL DIVIDEND OF $1.50 PER SHARE - TradingView
Cumberland Pharmaceuticals (CPIX) Sees Modest Decline, Tests Key Support ZonePercent Above MA - dars.gov.et
Cumberland outlines new product expansion and sees $8.3M Q3 revenues while advancing clinical pipeline - MSN
Cumberland Pharmaceuticals (CPIX) Plunges Over 10% as Selling Pressure IntensifiesTriangle Correction - dars.gov.et
Cumberland Pharmaceuticals (CPIX) Slides 11.6%: Testing Key Support Near $5.98ETH Profile - dars.gov.et
Cumberland Pharmaceuticals Sells Branded Drug Portfolio to Apotex for $100M, Refocuses on Rare Disease Pipeline 1 - Minichart
CPIXCumberland Pharmaceuticals Inc Latest SEC Filings - Finviz
Cumberland Refocuses on Rare Disease Pipeline After Asset Sale - TipRanks
Cumberland (CPIX) nets $100M from Apotex deal, shifts to rare disease pipeline - Stock Titan
Cumberland Pharmaceuticals closes $100 million sale of drug portfolio - The Business Journals
Cumberland sells branded drug portfolio to Apotex for $100m By Investing.com - Investing.com South Africa
Cumberland sells branded drug portfolio to Apotex for $100m - Investing.com
Apotex Completes Previously Announced Strategic Transaction with Cumberland Pharmaceuticals - Financial Times
Cumberland Pharmaceuticals (CPIX) Slips 3.65% — Testing Key Support Near $6.26Overvalued Signals - dars.gov.et
Cumberland Pharma advances Duchenne program with new safety, efficacy data - MSN
Cumberland Pharma Advances Duchenne Program With New Safety, Efficacy Data - Sahm
Cumberland shares updated trial results for DMD heart therapy - Investing.com UK
Why Is Cumberland Pharma Stock Gaining Friday?Cumberland Pharma (NASDAQ:CPIX) - Benzinga
Cumberland says updated DMD heart data strengthen ifetroban case - Stock Titan
0.79%
5.15%
자본화:
|
볼륨(24시간):